Filtros de búsqueda

Lista de obras de Elliott M Antman

2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in coll

artículo científico publicado en 2007

2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

artículo científico publicado en 2008

2007 focused update to the ACC/AHA guidelines for the management of patients with ST-segment elevation myocardial infarction: implications for emergency department practice

artículo científico publicado en 2008

2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (updating the 200

artículo científico publicado en 2009

2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention

artículo científico publicado en 2009

2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 200

scientific article published on December 2009

2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction ⬇️

artículo científico publicado el 28 de marzo de 2011

2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Associati

artículo científico publicado en 2011

2011 ACCF/AHA focused update of the Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction (updating the 2007 guideline): a report of the American College of Cardiology Foundation/American Heart Associa

artículo científico publicado en 2011

2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Associat

artículo científico publicado en 2013

2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS

artículo científico publicado en 2017

A novel risk prediction score in atrial fibrillation for a net clinical outcome from the ENGAGE AF-TIMI 48 randomized clinical trial

artículo científico publicado en 2017

A perspective on the efficacy and safety of intensive antiplatelet therapy in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38.

artículo científico publicado en 2008

A strategy of using enoxaparin as adjunctive antithrombin therapy reduces death and recurrent myocardial infarction in patients who achieve early ST-segment resolution after fibrinolytic therapy: the ExTRACT-TIMI 25 ECG study

artículo científico publicado en 2007

A subgroup analysis of the impact of prerandomization antithrombin therapy on outcomes in the SYNERGY trial: enoxaparin versus unfractionated heparin in non-ST-segment elevation acute coronary syndromes

scientific article published on 12 September 2006

ACC/AHA 2002 Guideline Update for the Management of Patients With Chronic Stable Angina—Summary Article

artículo científico publicado en 2003

ACC/AHA 2002 guideline update for exercise testing: summary article

artículo científico publicado en 2002

ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines).

artículo científico publicado en 2002

ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice g

artículo científico publicado en 2002

ACC/AHA 2004 Guideline Update for Coronary Artery Bypass Graft Surgery: Summary Article

ACC/AHA 2004 Guideline Update for Coronary Artery Bypass Graft Surgery: Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary

artículo científico publicado en 2004

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the [...]

artículo científico publicado en 2005

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article

ACC/AHA 2005 Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic): A Collaborative Report from the American Association for Vascular Surgery/Society for Vascular Surgery

ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascul

artículo científico publicado en 2006

ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society f

artículo científico publicado en 2006

ACC/AHA 2006 Guideline Update on Perioperative Cardiovascular Evaluation for Noncardiac Surgery: Focused Update on Perioperative Beta-Blocker Therapy

article

ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

article

ACC/AHA 2006 Practice Guidelines for the Management of Patients With Valvular Heart Disease: Executive Summary

article

ACC/AHA 2006 guideline update on perioperative cardiovascular evaluation for noncardiac surgery: focused update on perioperative beta-blocker therapy: a report of the American College of Cardiology/American Heart Association Task Force on Practice G

artículo científico publicado en 2006

ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction

artículo científico publicado en 2007

ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery

article

ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary

article

ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary

scholarly article by Lee A. Fleisher et al published March 2008 in Anesthesia & Analgesia

ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to R

artículo científico publicado en 2007

ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Rev

artículo científico publicado en 2007

ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Gui

artículo científico publicado en 2007

ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Managemen

artículo científico publicado en 2008

ACC/AHA Guideline Update for Perioperative Cardiovascular Evaluation for Noncardiac Surgery--Executive Summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996

artículo científico publicado en 2002

ACC/AHA Guideline Update for the Management of Patients With Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction--2002: Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice G

article by Eugene Braunwald et al published 1 October 2002 in Circulation

ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction—Executive Summary

article published 3 August 2004 in Circulation

ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery---executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996

artículo científico publicado en 2002

ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery—executive summary

article

ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary

artículo científico publicado en 2002

ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise th

artículo científico publicado en 2004

ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise th

artículo científico publicado en 2004

ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the M

artículo científico publicado en 2004

ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction; A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the M

artículo científico publicado en 2004

ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997

artículo científico publicado en 2003

ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 199

artículo científico publicado en 2003

ACC/AHA/ASNC Guidelines for the Clinical Use of Cardiac Radionuclide Imaging—Executive Summary

article

ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 G

artículo científico publicado en 2003

ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiolo

artículo científico publicado en 2006

ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death—Executive Summary

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

artículo científico publicado en 2006

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation—Executive Summary

ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European S

artículo científico publicado en 2006

ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiolog

artículo científico publicado en 2006

ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiolo

artículo científico publicado en 2006

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--excutive summary

artículo científico publicado en 2007

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiolog

artículo científico publicado en 2006

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committ

scientific article published on 01 September 2006

ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary. a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardi

artículo científico publicado en 2003

ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardi

artículo científico publicado en 2003

ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antirrhythmia Devices: Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committe

artículo científico publicado en 2002

ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention

article

ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention—Summary Article

article published 3 January 2006 in Circulation

ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention—Summary Article

article by Sidney C Smith et al published January 2006 in Journal of the American College of Cardiology

ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention—summary article: A report of the American college of cardiology/American heart association task force on practice guidelines(ACC/AHA/SCAI writing committee to update the 2001

article published in 2005

ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use

scientific article published on 03 October 2008

ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use.

artículo científico publicado en 2008

ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents

artículo científico publicado en 2008

ACCF/ACG/AHA 2010 Expert Consensus Document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and

scientific article published on 08 November 2010

ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and

artículo científico publicado el 7 de diciembre de 2010

ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and

scholarly article published in 2010

ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

artículo científico

ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

artículo científico publicado en 2012

Abciximab as Adjunctive Therapy to Reperfusion in Acute ST-Segment Elevation Myocardial Infarction

scientific article published in The Journal of the American Medical Association

Acquisition, Analysis, and Sharing of Data in 2015 and Beyond: A Survey of the Landscape: A Conference Report From the American Heart Association Data Summit 2015

artículo científico publicado en 2015

Activated partial thromboplastin time measurement is not associated with clinical outcomes in patients with high-risk non-ST-segment elevation acute coronary syndromes treated with unfractionated heparin ⬇️

artículo científico publicado el 1 de julio de 2012

Actualización ESC 2017 sobre el tratamiento antiagregante plaquetario doble en la enfermedad coronaria, desarrollada en colaboración con la EACTS

Acute ST-segment elevation myocardial infarction and prior stroke: an analysis from the Magnesium in Coronaries (MAGIC) trial

artículo científico publicado en 2004

All opinions are not equal

scientific article published on 01 January 2004

American College of Cardiology/American Heart Association clinical practice guidelines: Part I: where do they come from?

artículo científico publicado en 2003

American College of Cardiology/American Heart Association clinical practice guidelines: Part II: evolutionary changes in a continuous quality improvement project

artículo científico publicado en 2003

American College of Cardiology/American Heart Association/European Society of Cardiology/World Heart Federation Universal Definition of Myocardial Infarction Classification System and the Risk of Cardiovascular Death ⬇️

artículo científico publicado el 23 de diciembre de 2011

American Heart Association Principles on the Accessibility and Affordability of Drugs and Biologics: A Presidential Advisory From the American Heart Association

artículo científico publicado en 2017

Angiographic and clinical characteristics associated with the development of Q-wave and non-Q-wave myocardial infarction in the thrombolysis in myocardial infarction (TIMI) 14 trial

artículo científico publicado en 2003

Angiographic and clinical outcomes among patients with acute coronary syndromes presenting with isolated anterior ST-segment depression: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Pra

artículo científico publicado en 2010

Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial

artículo científico publicado en 2005

Angiographic perfusion score: an angiographic variable that integrates both epicardial and tissue level perfusion before and after facilitated percutaneous coronary intervention in acute myocardial infarction

artículo científico publicado en 2004

Angiography and revascularization in patients with heart failure following fibrinolytic therapy for ST-elevation acute myocardial infarction.

artículo científico publicado en 2005

Application of the Thrombolysis in Myocardial Infarction risk index in non-ST-segment elevation myocardial infarction: evaluation of patients in the National Registry of Myocardial Infarction

artículo científico publicado en 2006

Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial

artículo científico publicado en 2015

Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes

artículo científico publicado en 2003

Association of a history of systemic hypertension with mortality, thrombotic, and bleeding complications following non-ST-segment elevation acute coronary syndrome

artículo científico publicado en 2006

Association of a negative residual stenosis following rescue/adjunctive percutaneous coronary intervention with impaired myocardial perfusion and adverse outcomes among ST-segment elevation myocardial infarction patients

artículo científico publicado en 2005

Association of a pulsatile blood flow pattern on coronary arteriography and short-term clinical outcomes in acute myocardial infarction

artículo científico publicado en 2004

Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality

artículo científico publicado en 2003

Association of culprit lesion calcium with angiographic and clinical outcomes in patients with ST-elevation myocardial infarction treated with fibrinolytic therapy

artículo científico publicado en 2005

Association of duration of symptoms at presentation with angiographic and clinical outcomes after fibrinolytic therapy in patients with ST-segment elevation myocardial infarction

scientific article published on 01 September 2004

Association of epicardial and tissue-level reperfusion with left ventricular end-diastolic pressures in ST-elevation myocardial infarction

scientific article published on 01 June 2004

Association of glomerular filtration rate on presentation with subsequent mortality in non-ST-segment elevation acute coronary syndrome; observations in 13,307 patients in five TIMI trials

artículo científico publicado en 2004

Association of lesion complexity following fibrinolytic administration with mortality in ST-elevation myocardial infarction

artículo científico publicado en 2004

Association of non-steroidal anti-inflammatory drugs with outcomes in patients with ST-segment elevation myocardial infarction treated with fibrinolytic therapy: an ExTRACT-TIMI 25 analysis

artículo científico publicado en 2008

Association of platelet count with residual thrombus in the myocardial infarct-related coronary artery among patients treated with fibrinolytic therapy for ST-segment elevation acute myocardial infarction

artículo científico publicado en 2004

Association of smoking with improved myocardial perfusion and the angiographic characterization of myocardial tissue perfusion after fibrinolytic therapy for ST-segment elevation myocardial infarction

artículo científico publicado en 2005

Association of the Fibonacci Cascade with the distribution of coronary artery lesions responsible for ST-segment elevation myocardial infarction

artículo científico publicado en 2003

B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy

scientific article published on 01 July 2004

Baseline hemoglobin concentration and creatinine clearance composite laboratory index improves risk stratification in ST-elevation myocardial infarction

artículo científico publicado en 2009

Biomarker release after percutaneous coronary intervention: a message from the heart

artículo científico publicado en 2008

Bivalirudin as a replacement for unfractionated heparin in unstable angina/non-ST-elevation myocardial infarction: observations from the TIMI 8 trial. The Thrombolysis in Myocardial Infarction

artículo científico publicado en 2002

Bleeding complications in patients with acute coronary syndrome undergoing early invasive management can be reduced with radial access, smaller sheath sizes, and timely sheath removal

artículo científico publicado en 2007

Bypassing the emergency department to improve the process of care for ST-elevation myocardial infarction: necessary but not sufficient

artículo científico publicado en 2013

CMR quantification of infarct tissue heterogeneity and remote myocardial fibrotic burden during convalescent phase following acute myocardial infarction (MI) provided strong and complementary evidence of ventricular arrhythmogenicity from quantitativ

Cardiology patient pages. Modern treatment for heart attacks: opening blocked arteries quickly

artículo científico publicado en 2006

Cardiovascular Biomarker Score and Clinical Outcomes in Patients With Atrial Fibrillation: A Subanalysis of the ENGAGE AF-TIMI 48 Randomized Clinical Trial

artículo científico

Cardiovascular- and Bleeding-Related Hospitalization Rates With Edoxaban Versus Warfarin in Patients With Atrial Fibrillation Based on Results of the ENGAGE AF-TIMI 48 Trial

artículo científico publicado en 2020

Cerebrovascular events in 21 105 patients with atrial fibrillation randomized to edoxaban versus warfarin: Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48.

artículo científico

Characterization of subacute and convalescent fibrotic burden in the remote myocardium after acute infarction provides strong and incremental prediction of changes in left and right functions and final infarct size, incremental to knowledge of the s

artículo científico publicado en 2012

Circadian variation in patient characteristics and outcomes in ST-segment elevation myocardial infarction

artículo científico publicado en 2012

Circadian variation of stent thrombosis and the effect of more robust platelet inhibition: a post hoc analysis of the TRITON-TIMI 38 trial

artículo científico publicado en 2013

Clinical Application of a Novel Genetic Risk Score for Ischemic Stroke in Patients with Cardiometabolic Disease

artículo científico publicado en 2020

Clinical Practice Guidelines on Perioperative Cardiovascular Evaluation: collaborative efforts among the American College of Cardiology, the American Heart Association, and the European Society of Cardiology

artículo científico publicado en 2014

Clinical events after interruption of anticoagulation in patients with atrial fibrillation: An analysis from the ENGAGE AF-TIMI 48 trial

artículo científico publicado en 2018

Clinical guidelines and practice: in search of the truth

artículo científico publicado en 2006

Clinical outcomes, edoxaban concentration, and anti-factor Xa activity of Asian patients with atrial fibrillation compared with non-Asians in the ENGAGE AF-TIMI 48 trial

scientific article published on 01 May 2019

Clinical practice guidelines and scientific evidence

artículo científico publicado en 2009

Clinical practice guidelines for chronic cardiovascular disorders: a roadmap for the future

artículo científico publicado en 2014

Clinical practice guidelines on perioperative cardiovascular evaluation: collaborative efforts among the ACC, AHA, and ESC

artículo científico publicado en 2014

Clinical practice guidelines on perioperative cardiovascular evaluation: collaborative efforts among the ACC, AHA, and ESC

artículo científico publicado en 2014

Clinical research and the development of medical therapeutics

artículo científico

Clopidogrel resistance: a new chapter in a fast-moving story

artículo científico publicado en 2004

Combination of quantitative ST deviation and troponin elevation provides independent prognostic and therapeutic information in unstable angina and non-ST-elevation myocardial infarction

artículo científico publicado en 2006

Combined assessment of thrombolysis in myocardial infarction flow grade, myocardial perfusion grade, and ST-segment resolution to evaluate epicardial and myocardial reperfusion

artículo científico publicado en 2004

Combining enoxaparin and glycoprotein IIb/IIIa antagonists for the treatment of acute coronary syndromes: final results of the National Investigators Collaborating on Enoxaparin-3 (NICE-3) study

artículo científico publicado en 2003

Comparison of Events Across Bleeding Scales in the ENGAGE AF-TIMI 48 Trial

scientific article published on 10 October 2019

Comparison of enoxaparin versus unfractionated heparin in patients with unstable angina pectoris/non-ST-segment elevation acute myocardial infarction having subsequent percutaneous coronary intervention

artículo científico publicado en 2002

Comparison of site-reported and core laboratory-reported creatine kinase-MB values in non-ST-segment elevation acute coronary syndrome (from the international trial SYNERGY).

artículo científico publicado en 2009

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

artículo científico publicado en 2013

Comparison of the prognosis of spontaneous and percutaneous coronary intervention-related myocardial infarction.

artículo científico publicado en 2012

Concomitant Use of Single Antiplatelet Therapy With Edoxaban or Warfarin in Patients With Atrial Fibrillation: Analysis From the ENGAGE AF-TIMI48 Trial

artículo científico publicado en 2016

Concomitant administration of clopidogrel with statins or calcium-channel blockers: insights from the TRITON-TIMI 38 (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial inf

artículo científico publicado en 2013

Contributors

Coronary care medicine: it's not your father's CCU anymore

artículo científico publicado en 2004

Cost-effectiveness of edoxaban vs warfarin in patients with atrial fibrillation based on results of the ENGAGE AF-TIMI 48 trial

artículo científico publicado en 2015

Cost-effectiveness of prasugrel versus clopidogrel in patients with acute coronary syndromes and planned percutaneous coronary intervention: results from the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with

artículo científico publicado en 2009

Cost-effectiveness of providing full drug coverage to increase medication adherence in post-myocardial infarction Medicare beneficiaries

artículo científico publicado en 2008

Cyclooxygenase inhibition and cardiovascular risk

artículo científico publicado en 2005

Cytochrome P450 genetic polymorphisms and the response to prasugrel: relationship to pharmacokinetic, pharmacodynamic, and clinical outcomes

artículo científico publicado en 2009

Cytochrome p-450 polymorphisms and response to clopidogrel

artículo científico publicado en 2008

Data sharing in research: benefits and risks for clinicians

artículo científico publicado en 2014

Development of Systems of Care for ST-Elevation Myocardial Infarction Patients

Development of Systems of Care for ST-Elevation Myocardial Infarction Patients

Diabetes and mortality following acute coronary syndromes

artículo científico publicado en 2007

Differential expression of cardiac biomarkers by gender in patients with unstable angina/non-ST-elevation myocardial infarction: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy-T

artículo científico publicado en 2004

Digoxin Use and Subsequent Clinical Outcomes in Patients With Atrial Fibrillation With or Without Heart Failure in the ENGAGE AF-TIMI 48 Trial

artículo científico publicado en 2017

Diltiazem treatment for pre-clinical hypertrophic cardiomyopathy sarcomere mutation carriers: a pilot randomized trial to modify disease expression

artículo científico publicado en 2014

Direct comparison of characteristics, treatment, and outcomes of patients enrolled versus patients not enrolled in a clinical trial at centers participating in the TIMI 9 Trial and TIMI 9 Registry

artículo científico publicado en 2003

Discharge aspirin dose and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel: an analysis from the TRITON-TIMI 38 study (trial to assess improvement in therapeutic outcomes by optimizing platelet i

artículo científico publicado en 2013

Distance from the coronary ostium to the culprit lesion in acute ST-elevation myocardial infarction and its implications regarding the potential prevention of proximal plaque rupture

artículo científico publicado en 2003

Dual antiplatelet therapy for coronary stenting: a clear path for a research agenda

artículo científico publicado en 2005

Dynamic TIMI risk score for STEMI.

artículo científico publicado en 2013

Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thro

artículo científico publicado en 2008

Early and long-term clinical outcomes associated with reinfarction following fibrinolytic administration in the Thrombolysis in Myocardial Infarction trials

artículo científico publicado en 2003

Edoxaban Versus Warfarin Stratified by Average Blood Pressure in 19 679 Patients With Atrial Fibrillation and a History of Hypertension in the ENGAGE AF-TIMI 48 Trial

artículo científico publicado en 2019

Edoxaban Versus Warfarin in Atrial Fibrillation Patients at Risk of Falling: ENGAGE AF-TIMI 48 Analysis

artículo científico publicado en 2016

Edoxaban Versus Warfarin in Latin American Patients With Atrial Fibrillation: The ENGAGE AF-TIMI 48 Trial

artículo científico publicado en 2018

Edoxaban Versus Warfarin in Patients With Atrial Fibrillation and History of Liver Disease

scientific article published on 01 July 2019

Edoxaban and implantable cardiac device interventions: insights from the ENGAGE AF-TIMI 48 trial

artículo científico publicado en 2019

Edoxaban effects on bleeding following punch biopsy and reversal by a 4-factor prothrombin complex concentrate

artículo científico publicado en 2014

Edoxaban for the Prevention of Thromboembolism in Patients With Atrial Fibrillation and Bioprosthetic Valves

artículo científico publicado en 2017

Edoxaban in atrial fibrillation patients with established coronary artery disease: Insights from ENGAGE AF-TIMI 48

scientific article published on 24 July 2018

Edoxaban vs warfarin in patients with nonvalvular atrial fibrillation in the US Food and Drug Administration approval population: An analysis from the Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in My

artículo científico publicado en 2015

Edoxaban vs. warfarin in vitamin K antagonist experienced and naive patients with atrial fibrillation†

artículo científico publicado en 2015

Effect of Omega-3 Acid Ethyl Esters on Left Ventricular Remodeling After Acute Myocardial Infarction: The OMEGA-REMODEL Randomized Clinical Trial

artículo científico publicado en 2016

Effect of enoxaparin versus unfractionated heparin in diabetic patients with ST-elevation myocardial infarction in the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (

artículo científico publicado en 2007

Effect of prasugrel versus clopidogrel on outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention without stent implantation: a TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet inh

artículo científico publicado en 2009

Effect of rescue or adjunctive percutaneous coronary intervention of the culprit artery after fibrinolytic administration on epicardial flow in nonculprit arteries

artículo científico publicado en 2004

Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural myocardial infarction in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in My

artículo científico publicado en 2009

Effect of thrombocytopenia on outcomes following treatment with either enoxaparin or unfractionated heparin in patients presenting with acute coronary syndromes

artículo científico publicado en 2007

Efficacy and Safety of Edoxaban in Elderly Patients With Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial

artículo científico publicado en 2016

Efficacy and Safety of Edoxaban in Patients With Active Malignancy and Atrial Fibrillation: Analysis of the ENGAGE AF - TIMI 48 Trial

Efficacy and Safety of Intensive Antiplatelet Therapy With Prasugrel from TRITON-TIMI 38 in a Core Clinical Cohort Defined by Worldwide Regulatory Agencies ⬇️

artículo científico publicado el 2 de agosto de 2011

Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-Segment elevation acute coronary syndromes: a systematic overview

artículo científico publicado en 2004

Efficacy and safety of edoxaban compared with warfarin in patients with atrial fibrillation and heart failure: insights from ENGAGE AF-TIMI 48.

artículo científico publicado en 2016

Efficacy and safety of edoxaban in patients with diabetes mellitus in the ENGAGE AF-TIMI 48 trial

artículo científico publicado en 2020

Efficacy and safety of enoxaparin versus unfractionated heparin in patients with ST-segment elevation myocardial infarction also treated with clopidogrel

artículo científico publicado en 2007

Efficacy and safety of the low-molecular weight heparin enoxaparin compared with unfractionated heparin across the acute coronary syndrome spectrum: a meta-analysis

artículo científico publicado en 2007

Enoxaparin 0.3 mg/kg IV supplement for patients transitioning to PCI after subcutaneous enoxaparin therapy for NSTE ACS: a subgroup analysis from the SYNERGY trial

artículo científico publicado en 2010

Enoxaparin and unfractionated heparin in acute coronary syndromes without ST-segment elevation

artículo científico publicado en 2002

Enoxaparin as adjunctive antithrombin therapy for ST-elevation myocardial infarction: results of the ENTIRE-Thrombolysis in Myocardial Infarction (TIMI) 23 Trial

artículo científico publicado en 2002

Enoxaparin versus unfractionated heparin as antithrombin therapy in patients receiving fibrinolysis for ST-elevation myocardial infarction. Design and rationale for the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatmen

artículo científico publicado en 2005

Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction

artículo científico publicado en 2006

Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial

artículo científico publicado en 2004

Enoxaparin vs. unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction in elderly and younger patients: results from ExTRACT-TIMI 25.

artículo científico publicado en 2007

Evaluating the Cardiovascular Safety of Nonsteroidal Anti-Inflammatory Drugs

artículo científico publicado en 2017

Evaluation of high-sensitivity assays for cardiac troponin

scientific article published on 21 November 2008

Evaluation of the association of proximal coronary culprit artery lesion location with clinical outcomes in acute myocardial infarction ⬇️

artículo científico publicado el 15 de octubre de 2003

Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation-Thrombolysis In Myocardial

artículo científico publicado en 2010

Evaluation of the time saved by prehospital initiation of reteplase for ST-elevation myocardial infarction: results of The Early Retavase-Thrombolysis in Myocardial Infarction (ER-TIMI) 19 trial

artículo científico publicado en 2002

Evidence-Based Policy Making: Assessment of the American Heart Association's Strategic Policy Portfolio: A Policy Statement From the American Heart Association

artículo científico publicado en 2016

Extent of ST-segment resolution after fibrinolysis adds improved risk stratification to clinical risk score for ST-segment elevation myocardial infarction

artículo científico publicado en 2010

Fibrinolysis for acute myocardial infarction: the future is here and now.

artículo científico publicado en 2003

Fibrinolysis use among patients requiring interhospital transfer for ST-segment elevation myocardial infarction care: a report from the US National Cardiovascular Data Registry

artículo científico publicado en 2015

First experience with edoxaban and atrial fibrillation ablation - Insights from the ENGAGE AF-TIMI 48 trial

artículo científico publicado en 2017

Fourth universal definition of myocardial infarction (2018)

article by Kristian Thygesen et al published 25 August 2018 in European Heart Journal

Full Coverage for Preventive Medications after Myocardial Infarction

artículo científico publicado en 2011

Full prescription coverage versus usual prescription coverage after coronary artery bypass graft surgery: analysis from the post-myocardial infarction free Rx event and economic evaluation (FREEE) randomized trial

artículo científico publicado en 2013

Gastrointestinal Bleeding With Edoxaban Versus Warfarin: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis In Myocardial Infarction)

scientific article published on 01 May 2018

Genetic profiling of fatty acid desaturase polymorphisms identifies patients who may benefit from high-dose omega-3 fatty acids in cardiac remodeling after acute myocardial infarction-Post-hoc analysis from the OMEGA-REMODEL randomized controlled tr

artículo científico publicado en 2019

Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON-TIMI 38 trial: a pharmacogenetic analysis

artículo científico publicado en 2010

Genetics and the clinical response to warfarin and edoxaban: findings from the randomised, double-blind ENGAGE AF-TIMI 48 trial

artículo científico publicado en 2015

Geographic variability in patient characteristics, treatment and outcome in an International Trial of Magnesium in acute myocardial infarction.

artículo científico publicado en 2004

Global outcomes of ST-elevation myocardial infarction: comparisons of the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) registry and trial.

artículo científico publicado en 2007

Glycoprotein IIb/IIIa inhibitors in patients with unstable angina/non-ST–segment elevation myocardial infarction: Appropriate interpretation of the guidelines ⬇️

artículo científico publicado el 1 de octubre de 2003

Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocar

artículo científico publicado en 2008

Has guideline development gone astray? No

scientific article published on 29 January 2010

Hemodynamic significance of periprocedural myocardial injury assessed with N-terminal pro-B-type natriuretic peptide after percutaneous coronary intervention in patients with stable and unstable coronary artery disease (from the JUMBO-TIMI 26 trial)

artículo científico publicado en 2006

High-risk patients with acute coronary syndromes treated with low-molecular-weight or unfractionated heparin: outcomes at 6 months and 1 year in the SYNERGY trial

artículo científico publicado en 2005

Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy

artículo científico publicado en 2006

Identification of patients at high risk for death and cardiac ischemic events after hospital discharge

artículo científico publicado en 2002

Impact of Renal Function on Outcomes With Edoxaban in the ENGAGE AF-TIMI 48 Trial

artículo científico

Impact of Spontaneous Extracranial Bleeding Events on Health State Utility in Patients with Atrial Fibrillation: Results from the ENGAGE AF-TIMI 48 Trial

artículo científico publicado en 2017

Impact of diabetes mellitus on epicardial and microvascular flow after fibrinolytic therapy

artículo científico publicado en 2002

Impact of gender on angiographic and clinical outcomes after fibrinolytic therapy in acute myocardial infarction

scientific article published on 01 October 2002

Improving Care of STEMI in the United States 2008 to 2012

article

Improving Quality of Cardiac Care: A Global Mandate

artículo científico publicado en 2015

Influence of patient characteristics and renal function on factor Xa inhibition pharmacokinetics and pharmacodynamics after enoxaparin administration in non-ST-segment elevation acute coronary syndromes

artículo científico publicado en 2002

Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a r

artículo científico publicado en 2008

Intrinsic platelet reactivity before P2Y12 blockade contributes to residual platelet reactivity despite high-level P2Y12 blockade by prasugrel or high-dose clopidogrel. Results from PRINCIPLE-TIMI 44

artículo científico publicado en 2011

Invasive therapy along with glycoprotein IIb/IIIa inhibitors and intracoronary stents improves survival in non-ST-segment elevation acute coronary syndromes: a meta-analysis and review of the literature

artículo científico publicado en 2004

Is fondaparinux safer than enoxaparin for patients undergoing percutaneous coronary intervention?

artículo científico publicado en 2008

Left atrial structure and function and the risk of death or heart failure in atrial fibrillation

scientific article published on 27 November 2019

Left atrial structure and function in atrial fibrillation: ENGAGE AF-TIMI 48.

artículo científico publicado en 2013

Linking Endogenous Factor Xa Activity, a Biologically Relevant Pharmacodynamic Marker, to Edoxaban Plasma Concentrations and Clinical Outcomes in the ENGAGE AF-TIMI 48 Trial

artículo científico publicado en 2018

Low molecular weight heparins for acute coronary syndrome: tackling the issues head-on

artículo científico publicado en 2003

Low-molecular-weight heparin therapy for non-ST-elevation acute coronary syndromes and during percutaneous coronary intervention: an expert consensus

artículo científico publicado en 2002

Management of Bleeding With Non-Vitamin K Antagonist Oral Anticoagulants in the Era of Specific Reversal Agents

artículo científico publicado en 2016

Managing Stable Ischemic Heart Disease

scientific article published on 30 March 2020

Mejorar la calidad de la asistencia cardiaca: un imperativo mundial

Methodologic and clinical validation of the TIMI myocardial perfusion grade in acute myocardial infarction

artículo científico publicado en 2002

Minimal ST-segment deviation: a simple, noninvasive method for identifying patients with a patent infarction-related artery after fibrinolytic administration

artículo científico publicado en 2002

Mode and timing of treatment failure (recurrent ischemic events) after hospital admission for non-ST segment elevation acute coronary syndromes

scientific article published on 01 January 2002

Modelling and simulation of edoxaban exposure and response relationships in patients with atrial fibrillation ⬇️

artículo científico publicado el 8 de marzo de 2012

Modes and timing of death in 66 252 patients with non-ST-segment elevation acute coronary syndromes enrolled in 14 TIMI trials

scientific article published on 01 November 2018

Mortality in Patients with Atrial Fibrillation Randomized to Edoxaban or Warfarin: Insights from the ENGAGE AF-TIMI 48 Trial

artículo científico publicado en 2016

Mortality in the TRITON trial: update from the FDA prasugrel action package

artículo científico publicado en 2010

Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide

artículo científico publicado en 2002

NIH Centers for Accelerated Innovations Program: principles, practices, successes and challenges

artículo científico publicado en 2017

New oral anticoagulants in patients with atrial fibrillation - Authors'reply

artículo científico publicado en 2014

Nonculprit Lesion Myocardial Infarction Following Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome

scientific article published on 01 March 2020

Obesity in patients with non-ST-segment elevation acute coronary syndromes: results from the SYNERGY trial

artículo científico publicado en 2008

One-year outcomes after a strategy using enoxaparin vs. unfractionated heparin in patients undergoing fibrinolysis for ST-segment elevation myocardial infarction: 1-year results of the ExTRACT-TIMI 25 trial

artículo científico publicado en 2010

Oral anticoagulation for atrial fibrillation after ST-elevation myocardial infarction: new evidence to guide clinical practice

artículo científico publicado en 2005

Otamixaban for the treatment of patients with non-ST-elevation acute coronary syndromes (SEPIA-ACS1 TIMI 42): a randomised, double-blind, active-controlled, phase 2 trial

artículo científico publicado en 2009

Outcomes With Edoxaban Versus Warfarin in Patients With Previous Cerebrovascular Events: Findings From ENGAGE AF-TIMI 48 (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48).

artículo científico

Outcomes and optimal antithrombotic therapy in women undergoing fibrinolysis for ST-elevation myocardial infarction

scientific article published on 21 May 2007

Outcomes of Women Compared With Men After Non-ST-Segment Elevation Acute Coronary Syndromes

scientific article published on 09 December 2019

PON1 Q192R genetic variant and response to clopidogrel and prasugrel: pharmacokinetics, pharmacodynamics, and a meta-analysis of clinical outcomes

article

Patients with diabetes mellitus and atrial fibrillation treated with NOACs: Meta-analysis of 8 outcomes in 58, 634 patients across 4 randomized controlled trials

artículo científico publicado en 2020

Patterns of long-term thienopyridine therapy and outcomes in patients with acute coronary syndrome treated with coronary stenting: Observations from the TIMI-38 Coronary Stent Registry.

artículo científico publicado en 2014

Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin after fibrinolytic therapy for ST-segment elevation myocardial infarction in the ExTRACT-TIMI 25 trial

artículo científico publicado en 2007

Performance of the ABC Scores for Assessing the Risk of Stroke or Systemic Embolism and Bleeding in Patients With Atrial Fibrillation in ENGAGE AF-TIMI 48

scientific article published on 01 February 2019

Performance of the thrombolysis in myocardial infarction risk index in the National Registry of Myocardial Infarction-3 and -4: a simple index that predicts mortality in ST-segment elevation myocardial infarction

artículo científico publicado en 2004

Peri-operative Adverse Outcomes in Patients with Atrial Fibrillation Taking Warfarin or Edoxaban: Analysis of the ENGAGE AF-TIMI 48 Trial

scientific article published on 03 May 2018

Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMI 38 trial

artículo científico publicado en 2009

Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials

artículo científico publicado en 2009

Pharmacogenetic-guided and clinical warfarin dosing algorithm assessments with bleeding outcomes risk-stratified by genetic and covariate subgroups

scientific article published on 21 March 2020

Pharmacoinvasive therapy: the future of treatment for ST-elevation myocardial infarction

artículo científico publicado en 2004

Poor outcomes after fibrinolytic therapy for ST-segment elevation myocardial infarction: impact of age (a meta-analysis of a decade of trials)

artículo científico publicado en 2006

Population and personalized medicine in the modern era.

artículo científico publicado en 2014

Population pharmacokinetic analyses to evaluate the influence of intrinsic and extrinsic factors on exposure of prasugrel active metabolite in TRITON-TIMI 38.

artículo científico publicado en 2009

Population pharmacokinetics and pharmacodynamics of enoxaparin in unstable angina and non-ST-segment elevation myocardial infarction

artículo científico publicado en 2003

Potent inhibition of thrombin with a monoclonal antibody against tissue factor (Sunol-cH36): results of the PROXIMATE-TIMI 27 trial

artículo científico publicado en 2005

Prasugrel

scientific article published on July 2010

Prasugrel Versus Clopidogrel in Patients With ST-Segment Elevation Myocardial Infarction According to Timing of Percutaneous Coronary Intervention

artículo científico publicado en 2014

Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial

artículo científico publicado en 2009

Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myoc

artículo científico publicado en 2007

Prasugrel versus clopidogrel in patients with acute coronary syndromes

artículo científico publicado en 2007

Precision medicine in cardiology

artículo científico publicado en 2016

Prediction of one-year survival in high-risk patients with acute coronary syndromes: results from the SYNERGY trial

artículo científico publicado en 2008

Predictors of bleeding and time dependence of association of bleeding with mortality: insights from the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel--Thrombolysis in Myocardial Infarction 38 (T

artículo científico

Predictors of initial nontherapeutic anticoagulation with unfractionated heparin in ST-segment elevation myocardial infarction

artículo científico publicado en 2009

Predictors of the rise in vWF after ST elevation myocardial infarction: implications for treatment strategies and clinical outcome: An ENTIRE-TIMI 23 substudy

artículo científico publicado en 2005

Primary percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: does the choice of fibrinolytic agent impact on the importance of time-to-treatment?

artículo científico publicado en 2004

Prognostic performance of a high-sensitivity cardiac troponin I assay in patients with non-ST-elevation acute coronary syndrome

artículo científico publicado en 2013

Randomized comparison of prasugrel (CS-747, LY640315), a novel thienopyridine P2Y12 antagonist, with clopidogrel in percutaneous coronary intervention: results of the Joint Utilization of Medications to Block Platelets Optimally (JUMBO)-TIMI 26 trial

artículo científico publicado en 2005

Rationale and design of the Post-MI FREEE trial: a randomized evaluation of first-dollar drug coverage for post-myocardial infarction secondary preventive therapies

artículo científico publicado en 2008

Recommendation to Develop Strategies to Increase the Number of ST-Segment–Elevation Myocardial Infarction Patients With Timely Access to Primary Percutaneous Coronary Intervention

article published in 2006

Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis

artículo científico publicado en 2010

Reducing the risk of heart attack and stroke: the American Heart Association/American College of Cardiology prevention guidelines

artículo científico publicado en 2014

Reduction in recurrent cardiovascular events with prasugrel compared with clopidogrel in patients with acute coronary syndromes from the TRITON-TIMI 38 trial

artículo científico publicado en 2008

Relation of impaired Thrombolysis In Myocardial Infarction myocardial perfusion grades to residual thrombus following the restoration of epicardial patency in ST-elevation myocardial infarction

artículo científico publicado en 2005

Relations between bleeding and outcomes in patients with ST-elevation myocardial infarction in the ExTRACT-TIMI 25 trial

artículo científico publicado en 2010

Relationship between renal function and outcomes in high-risk patients with non-ST-segment elevation acute coronary syndromes: results from SYNERGY.

artículo científico publicado en 2009

Reply

Reply: Anticoagulants in Atrial Fibrillation and Liver Disease

artículo científico publicado en 2019

Safety and efficacy of prasugrel compared with clopidogrel in different regions of the world

artículo científico publicado en 2010

Safety and efficacy of unfractionated heparin versus enoxaparin in patients who are obese and patients with severe renal impairment: analysis from the ESSENCE and TIMI 11B studies

artículo científico publicado en 2003

Saving and Improving Lives in the Information Age: Presidential Address at the American Heart Association 2014 Scientific Sessions

artículo científico publicado en 2015

Sequential risk stratification using TIMI risk score and TIMI flow grade among patients treated with fibrinolytic therapy for ST-segment elevation acute myocardial infarction

artículo científico publicado en 2004

Serial quantification of myocardial infarction tissue heterogeneity during infarct healing by cardiac MRI provides strong characterization of left ventricular remodeling (the NHLBI PROSPECT-CMR Study).

artículo científico publicado en 2011

Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction

artículo científico publicado en 2004

Severity of heart failure, treatments, and outcomes after fibrinolysis in patients with ST-elevation myocardial infarction

artículo científico publicado en 2004

Should bivalirudin replace heparin during percutaneous coronary interventions?

artículo científico publicado en 2003

Should evidence-based proof of efficacy as defined for a specific therapeutic agent be extrapolated to encompass a therapeutic class of agents?

artículo científico publicado en 2003

Should patients receive secondary prevention medications for free after a myocardial infarction? An economic analysis

artículo científico publicado en 2007

Smoking status and antithrombin therapy in patients with non-ST-segment elevation acute coronary syndrome.

artículo científico publicado en 2008

Sodium, blood pressure, and cardiovascular disease: further evidence supporting the American Heart Association sodium reduction recommendations

artículo científico publicado en 2012

Stakeholder discussion to reduce population-wide sodium intake and decrease sodium in the food supply: a conference report from the American Heart Association Sodium Conference 2013 Planning Group

artículo científico publicado en 2014

Standards for Clinical Research: Keeping Pace With the Technology of the Future

artículo científico publicado en 2016

Streptokinase and enoxaparin as an alternative to fibrin-specific lytic-based regimens: an ExTRACT-TIMI 25 analysis.

artículo científico publicado en 2009

Stroke and Mortality Risk in Patients With Various Patterns of Atrial Fibrillation: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48).

artículo científico

Sudden Cardiac Death in Patients With Atrial Fibrillation: Insights From the ENGAGE AF-TIMI 48 Trial

scientific article published on 08 July 2016

Superiority of enoxaparin over unfractionated heparin for the treatment of acute coronary syndromes

artículo científico publicado en 2002

Sustainable Development Goals and the future of cardiovascular health. A statement from the Global Cardiovascular Disease Taskforce

artículo científico publicado en 2014

Sustainable Development Goals and the future of cardiovascular health: a statement from the Global Cardiovascular Disease Taskforce

artículo científico publicado en 2014

Sustainable Development goals and the future of cardiovascular health: a statement from the Global Cardiovascular Disease Taskforce

artículo científico publicado en 2014

Sustainable development goals and the future of cardiovascular health: a statement from the Global Cardiovascular Disease Taskforce

artículo científico publicado en 2014

Synthesis, grading, and presentation of evidence in guidelines: article 7 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report

artículo científico

Systemic, noncerebral, arterial embolism in 21,105 patients with atrial fibrillation randomized to edoxaban or warfarin: results from the Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infa

artículo científico publicado en 2015

Systems of care for ST-segment-elevation myocardial infarction: a report From the American Heart Association's Mission: Lifeline

artículo científico publicado en 2012

Systems pharmacology, pharmacogenetics, and clinical trial design in network medicine

artículo científico publicado en 2012

TIMI Risk Score for ST-Elevation Myocardial Infarction: A Convenient, Bedside, Clinical Score for Risk Assessment at Presentation : An Intravenous nPA for Treatment of Infarcting Myocardium Early II Trial Substudy

artículo científico publicado en 2000

TIMI risk index and the benefit of enoxaparin in patients with ST-elevation myocardial infarction

artículo científico publicado en 2007

Task force 1: The ACCF and AHA codes of conduct in human subjects research

artículo científico publicado en 2004

Tenecteplase and tirofiban in ST-segment elevation acute myocardial infarction: results of a randomized trial

artículo científico publicado en 2005

The 50th anniversary of the US surgeon general's report on tobacco: what we've accomplished and where we go from here

artículo científico publicado en 2014

The Changing Landscape of Randomized Clinical Trials in Cardiovascular Disease

artículo científico publicado en 2016

The Introduction and Clinical Use of Cardiac-Specific Troponin Assays

artículo científico publicado en 2017

The Prognostic Significance of Cardiac Structure and Function in Atrial Fibrillation: The ENGAGE AF-TIMI 48 Echocardiographic Substudy

artículo científico publicado en 2016

The Risk Score Profile: a novel approach to characterising the risk of populations enrolled in clinical studies

artículo científico publicado en 2004

The TIMI Risk Score for Unstable Angina/Non–ST Elevation MI

artículo científico publicado en 2000

The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part I: Pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease).

artículo científico publicado en 2006

The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part II: Clinical trial evidence (acute coronary syndromes through renal disease) and future directions

artículo científico publicado en 2006

The efficacy and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and coronary artery disease: A meta-analysis of randomized trials

article

The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizi

artículo científico publicado en 2009

The impact of postrandomization crossover of therapy in acute coronary syndromes care

artículo científico

The impact of renal dysfunction on outcomes in the ExTRACT-TIMI 25 trial

artículo científico publicado en 2007

The independent and combined risk of diabetes and non-endstage renal impairment in non-ST-segment elevation acute coronary syndromes

scientific article published on 09 January 2008

The prognostic value of serum myoglobin in patients with non-ST-segment elevation acute coronary syndromes. Results from the TIMI 11B and TACTICS-TIMI 18 studies

artículo científico publicado en 2002

The search for a biomarker of cardiac ischemia

artículo científico publicado en 2003

The smoker's paradox: insights from the angiographic substudies of the TIMI trials.

artículo científico publicado en 2002

The thrombolysis in myocardial infarction risk score in unstable angina/non-ST-segment elevation myocardial infarction

artículo científico publicado en 2003

Third Universal Definition of Myocardial Infarction

artículo científico publicado en 2012

Third Universal Definition of Myocardial Infarction

article

Third universal definition of myocardial infarction

artículo científico publicado en 2012

Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts

artículo científico publicado en 2004

Time is muscle in primary PCI: the strength of the evidence grows

artículo científico publicado en 2004

Time is muscle: translation into practice

artículo científico publicado en 2008

Time to coronary angiography and outcomes among patients with high-risk non ST-segment elevation acute coronary syndromes: results from the SYNERGY trial

artículo científico publicado en 2007

Transforming clinical trials in cardiovascular disease: mission critical for health and economic well-being

Transition of patients from blinded study drug to open-label anticoagulation: the ENGAGE AF-TIMI 48 trial

artículo científico publicado en 2014

Treatment and outcomes of patients with evolving myocardial infarction: experiences from the SYNERGY trial

artículo científico publicado en 2007

Underutilization of evidence-based medications in acute ST elevation myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 9 Registry.

artículo científico publicado en 2002

Universal definition of myocardial infarction

artículo científico publicado en 2007

Untangling the relationship between medication adherence and post-myocardial infarction outcomes: medication adherence and clinical outcomes

artículo científico publicado en 2013

Updated Clinical Practice Guidelines on Heart Failure: An International Alignment

artículo científico publicado en 2016

Updated Clinical Practice Guidelines on Heart Failure: An International Alignment

artículo científico publicado en 2016

Updated Clinical Practice Guidelines on Heart Failure: An International Alignment

artículo científico publicado en 2016

Updated Clinical Practice Guidelines on Heart Failure: An International Alignment

artículo científico publicado en 2016

Updated Clinical Practice Guidelines on Heart Failure: An International Alignment.

artículo científico publicado en 2016

Use of emergency medical service transport among patients with ST-segment-elevation myocardial infarction: findings from the National Cardiovascular Data Registry Acute Coronary Treatment Intervention Outcomes Network Registry-Get With The Guideline

artículo científico publicado en 2011

Use of low-molecular-weight heparins in the management of acute coronary artery syndromes and percutaneous coronary intervention

artículo científico publicado en 2003

Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association

artículo científico publicado en 2007

Usefulness of medical conferences.

artículo científico publicado el 4 de julio de 2012

Usefulness of tirofiban among patients treated without percutaneous coronary intervention (TIMI high risk patients in PRISM-PLUS).

artículo científico publicado en 2004

Validated risk score predicts the development of congestive heart failure after presentation with unstable angina or non-ST-elevation myocardial infarction: results from OPUS-TIMI 16 and TACTICS-TIMI 18.

artículo científico publicado en 2004

Validation of the thrombolysis in myocardial infarction (TIMI) risk score for unstable angina pectoris and non-ST-elevation myocardial infarction in the TIMI III registry

artículo científico publicado en 2002

Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 Trial

artículo científico publicado en 2017

Workplace wellness recognition for optimizing workplace health: a presidential advisory from the American Heart Association

artículo científico publicado en 2015

[Fourth universal definition of myocardial infarction (2018)]

artículo científico publicado en 2018

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda